Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-label Study In The Latin America Region Comparing The Safety And Efficacy Of Etanercept With Conventional Dmard Therapy In Subjects With Rheumatoid Arthritis.

NCT00848354 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00848354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00848354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-label Study In The Latin America Region Comparing The Safety And Efficacy Of Etanercept With Conventional Dmard Therapy In Subjects With Rheumatoid Arthritis.
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2009
Completion date
April 30, 2013
Enrollment
429 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis